Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FTC-146 PET/MRI in CRPS and Sciatica
NCT02753101Phase 1Completed
- Sponsor
- Stanford University
- Start
- Feb 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]-FTC-146 in complex regional pain syndrome (CRPS) and Sciatica, sponsored by Stanford University. Primary endpoint: Biodistribution of [18F]FTC-146 at 2 hours. Started Feb 2016; status: completed.
02
Drugs
[18F]-FTC-146
03
Conditions
complex regional pain syndrome (CRPS)Sciatica
Beyond the preview
Go deeper on NCT02753101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02753101.